Kevin Caliendo
Stock Analyst at UBS
(4.07)
# 1,671
Out of 5,076 analysts
414
Total ratings
56.9%
Success rate
5.6%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Reiterated: Hold | $673 → $700 | $653.96 | +7.04% | 2 | Oct 23, 2026 | |
| FTRE Fortrea Holdings | Rated: Hold | $22 → $24 | $23.92 | +0.33% | 2 | Oct 20, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Hold | $195 | $185.57 | +5.08% | 2 | Oct 20, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $345 | $278.32 | +23.96% | 2 | Oct 20, 2026 | |
| SDGR Schrödinger | Rated: Hold | $19 → $21 | $22.60 | -7.08% | 2 | Oct 20, 2026 | |
| DGX Quest Diagnostics | Rated: Hold | $245 → $250 | $243.28 | +2.76% | 21 | Oct 19, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | $380 | $329.93 | +15.18% | 23 | Oct 19, 2026 | |
| CAH Cardinal Health | Reiterated: Buy | $274 → $295 | $255.64 | +15.40% | 24 | Oct 16, 2026 | |
| COR Cencora | Reiterated: Buy | $430 → $400 | $338.48 | +18.18% | 28 | Oct 16, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,080 → $1,200 | $1,012.34 | +18.54% | 34 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $10 | $10.09 | -0.89% | 1 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $357 | $339.66 | +5.11% | 1 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $43 | $34.88 | +23.28% | 4 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $27 | $23.97 | +12.64% | 6 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $126 → $118 | $94.48 | +24.89% | 36 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $6.17 | +62.07% | 19 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $1.5 | $0.2108 | +611.57% | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $3.75 | $3.62 | +3.59% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $89 → $94 | $86.00 | +9.30% | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $33 | $28.98 | +13.87% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $186 → $189 | $155.51 | +21.54% | 26 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $6.32 | -5.06% | 16 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.89 | +2.25% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $13 | $12.56 | +3.50% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $17 | $9.50 | +78.95% | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 → $78 | $87.45 | -10.81% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $375 | $315.88 | +18.72% | 11 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $18 | $8.43 | +113.52% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 → $180 | $216.64 | n/a | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $9 | $14.19 | n/a | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $250 → $285 | $420.97 | n/a | 12 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $72 → $79 | $71.24 | n/a | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $520 → $640 | $424.98 | n/a | 10 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $595 → $610 | $445.28 | n/a | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $180 → $175 | $267.61 | n/a | 4 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $14.14 | n/a | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $8 | $4.90 | n/a | 2 | Mar 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $102.00 | n/a | 1 | Jan 30, 2018 |
Medpace Holdings
Oct 23, 2026
Reiterated: Hold
Price Target: $673 → $700
Current: $653.96
Upside: +7.04%
Fortrea Holdings
Oct 20, 2026
Rated: Hold
Price Target: $22 → $24
Current: $23.92
Upside: +0.33%
ICON Public Limited Company
Oct 20, 2026
Reiterated: Hold
Price Target: $195
Current: $185.57
Upside: +5.08%
IQVIA Holdings
Oct 20, 2026
Reiterated: Buy
Price Target: $345
Current: $278.32
Upside: +23.96%
Schrödinger
Oct 20, 2026
Rated: Hold
Price Target: $19 → $21
Current: $22.60
Upside: -7.08%
Quest Diagnostics
Oct 19, 2026
Rated: Hold
Price Target: $245 → $250
Current: $243.28
Upside: +2.76%
Labcorp Holdings
Oct 19, 2026
Reiterated: Buy
Price Target: $380
Current: $329.93
Upside: +15.18%
Cardinal Health
Oct 16, 2026
Reiterated: Buy
Price Target: $274 → $295
Current: $255.64
Upside: +15.40%
Cencora
Oct 16, 2026
Reiterated: Buy
Price Target: $430 → $400
Current: $338.48
Upside: +18.18%
McKesson
Oct 16, 2026
Reiterated: Buy
Price Target: $1,080 → $1,200
Current: $1,012.34
Upside: +18.54%
Oct 2, 2026
Initiated Coverage: Hold
Price Target: $10
Current: $10.09
Upside: -0.89%
Sep 30, 2026
Initiated Coverage: Buy
Price Target: $357
Current: $339.66
Upside: +5.11%
Sep 25, 2026
Rated: Buy
Price Target: $50 → $43
Current: $34.88
Upside: +23.28%
Sep 18, 2026
Reiterated: Hold
Price Target: $25 → $27
Current: $23.97
Upside: +12.64%
Sep 3, 2026
Rated: Buy
Price Target: $126 → $118
Current: $94.48
Upside: +24.89%
Aug 24, 2026
Rated: Buy
Price Target: $10
Current: $6.17
Upside: +62.07%
Aug 13, 2026
Reiterated: Hold
Price Target: $4.5 → $1.5
Current: $0.2108
Upside: +611.57%
Aug 13, 2026
Reiterated: Hold
Price Target: $2 → $3.75
Current: $3.62
Upside: +3.59%
Aug 5, 2026
Reiterated: Hold
Price Target: $89 → $94
Current: $86.00
Upside: +9.30%
Jul 30, 2026
Reiterated: Buy
Price Target: $37 → $33
Current: $28.98
Upside: +13.87%
Jul 23, 2026
Reiterated: Hold
Price Target: $186 → $189
Current: $155.51
Upside: +21.54%
May 15, 2026
Reiterated: Hold
Price Target: $6
Current: $6.32
Upside: -5.06%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $4.89
Upside: +2.25%
May 8, 2026
Reiterated: Buy
Price Target: $12 → $13
Current: $12.56
Upside: +3.50%
May 7, 2026
Reiterated: Buy
Price Target: $18 → $17
Current: $9.50
Upside: +78.95%
May 6, 2026
Reiterated: Hold
Price Target: $82 → $78
Current: $87.45
Upside: -10.81%
Feb 9, 2026
Reiterated: Buy
Price Target: $390 → $375
Current: $315.88
Upside: +18.72%
Oct 31, 2025
Reiterated: Hold
Price Target: $17 → $18
Current: $8.43
Upside: +113.52%
Jul 25, 2025
Reiterated: Hold
Price Target: $374 → $180
Current: $216.64
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $12 → $9
Current: $14.19
Upside: n/a
Feb 24, 2025
Reiterated: Hold
Price Target: $250 → $285
Current: $420.97
Upside: n/a
Dec 21, 2023
Reiterated: Hold
Price Target: $72 → $79
Current: $71.24
Upside: n/a
Oct 16, 2023
Upgraded: Buy
Price Target: $520 → $640
Current: $424.98
Upside: n/a
Oct 24, 2022
Reiterated: Buy
Price Target: $595 → $610
Current: $445.28
Upside: n/a
Oct 3, 2022
Reiterated: Hold
Price Target: $180 → $175
Current: $267.61
Upside: n/a
Mar 9, 2022
Upgraded: Buy
Price Target: n/a
Current: $14.14
Upside: n/a
Mar 3, 2020
Reiterated: Hold
Price Target: $12 → $8
Current: $4.90
Upside: n/a
Jan 30, 2018
Upgraded: Buy
Price Target: n/a
Current: $102.00
Upside: n/a